An entrepreneur and venture investor in technology and life science, Andras is the cofounder and chief executive of Modern Meadow. Previously, he had also co-founded Organovo (NASDAQ: ONVO), a leader in tissue engineering which pioneered the use of 3D bioprinting to create human tissue for a range of medical applications. Organovo’s bio-printer was named one of the top inventions by TIME and the company was recognized by MIT Technology Review on its TR50 list of most innovative companies as well as by the World Economic Forum as a Technology Pioneer. Andras also served as managing director with Richmond Global, an international technology-focused venture fund. Previously, Andras was a consultant in the New York office of McKinsey & Company, focused on biopharma and private equity. Earlier, he was a founding member of Citigroup’s corporate and investment banking ecommerce group where he led a team that developed award winning financial technology products and ad vised large cap corporate clients on a range of corporate finance challenges. He is also co-founder and chairman emeritus of the international non-profit Resolution Project. Andras is a Kauffman Fellow with the Center for Venture Education and a term member with the Council on Foreign Relations. He holds an MBA from the Wharton School of Business and a Bachelor of Arts with honors from Harvard University.